Harvard Perspectives on Prostate Disease

Reason for hope

A message from Editor in Chief Marc B. Garnick, M.D.

Aside from the initial diagnosis of prostate cancer, learning that he has androgen-independent prostate cancer — disease that no longer responds to first-line hormone therapy medications — is perhaps the most devastating news for a patient. A decade ago, it meant that the patient was running out of treatment options; cancer was winning the war. But with new drugs on the market and in clinical trials, that same patient has many more choices today, including second-line hormone therapies and chemotherapy. Science has given us reason for hope.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »